학술논문
Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy
Document Type
Article
Author
Source
In: Cardiovascular Research . (Cardiovascular Research, 1 February 2020, 116(2):329-338)
Subject
Language
English
ISSN
17553245
00086363
00086363